Controlling the genome guardian

Scientists at Israel’s Weizmann Institute have been able to silence the gene controlling the p53 protein known as “the guardian of the genome”. The p53 protein is mutated or dysfunctional in over two-thirds of all cancers. Korean biotech BioLeaders is investing $10 million in the new Israeli therapy.

https://wis-wander.weizmann.ac.il/life-sciences/switching-sides-betrayal-anti-cancer-gene

https://www.timesofisrael.com/south-korea-firm-to-invest-10m-in-weizmann-scientists-anti-cancer-drug/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *